Four details:
1. Pacira’s bupivacaine liposome injectable suspension product is used in a variety of procedures, including orthopedic and spine surgeries.
2. The FDA approved Exparel for adults in 2011 and now will allow surgeons to use the product for pediatric patients ages 6 years and older.
3. Exparel is the first long-acting local anesthetic approved for pediatric use. The approval is based on a phase 3 study of Exparel in pediatric patients undergoing spine and cardiac procedures, which found no safety concerns.
4. More than 8 million patients have received Exparel for nonopioid pain control.
More articles on anesthetics:
How incorrectly documenting your anesthesia service can cost you your reimbursement
7 anesthesia company notes so far in 2021
Anesthesia market to hit $2.4B by 2025, market report says
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
